TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16335772

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention including nutrition, health and literacy education for mothers, improved growth monitoring, fostering rural cooperatives and income generation schemes.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control areas (no specific intervention mentioned).
Number of subjects: 0
Study: 11125687

Group type: EXPERIMENTAL
Intervention: Intra-articular ketamine 0.5 mg/kg diluted with saline up to 5 mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intra-muscular ketamine 0.5 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline 5 mL intra-articularly (control)
Number of subjects: 60
Study: 9334157

Group type: EXPERIMENTAL
Intervention: Epithelial structures
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Majority of cells
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cells of myxoid areas
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fibrous areas
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Characteristics of ECM
Number of subjects: 14
Study: 8420041

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: H‐ALG
Number of subjects: 3

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 3
Study: 3526500

Group type: EXPERIMENTAL
Intervention: Leucine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 30379749

Group type: EXPERIMENTAL
Intervention: Vasopressors (Norepinephrine, epinephrine, metaraminol, or vasopressin)
Number of subjects: 1588
Study: 28121470

Group type: EXPERIMENTAL
Intervention: Wheatgrass (Triticum aestivum L.) 3.5 g freeze-dried powder daily for 10 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 59
Study: 24989067

Group type: EXPERIMENTAL
Intervention: Joint Mobilizations (3 weeks, two sessions per week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham Mobilizations (same duration as joint mobilization)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 23832863

Group type: EXPERIMENTAL
Intervention: 0.3 µg/kg SPA (n = 8)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.45 µg/kg SPA (n = 8)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 4)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 0.3 µg/kg and 0.45 µg/kg SPA
Number of subjects: 20
Study: 22111826

Group type: EXPERIMENTAL
Intervention: Frozen saphenous vein A-V fistula
Number of subjects: 70

Group type: COMPARATOR
Intervention: Gore-tex A-V fistula
Number of subjects: 70
Study: 19249698

Group type: EXPERIMENTAL
Intervention: Modified vaginal hysterectomy method; details on dosage and duration not applicable.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard surgical methods; details on dosage and duration not applicable.
Number of subjects: 0
Study: 18666468

Group type: EXPERIMENTAL
Intervention: Triac (19.6 ug/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: L-T4 (1.7 ug/kg)
Number of subjects: 36
Study: 16479742

Group type: EXPERIMENTAL
Intervention: Polyhexamethylene biguanide cream
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 12160574

Group type: EXPERIMENTAL
Intervention: Conditions without blanking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conditions with blanking (60 ms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conditions with blanking (220 ms)
Number of subjects: 0
Study: 10219333

Group type: EXPERIMENTAL
Intervention: G-CSF (5 mcg/kg subcutaneous injection daily from day 9 until neutrophil count exceeds 0.5 x 10(9)/l for 3 days)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: G-CSF after second intensification
Number of subjects: 17
Study: 7834973

Group type: EXPERIMENTAL
Intervention: Iohexol in polypropylene containers
Number of subjects: 1481

Group type: COMPARATOR
Intervention: Iohexol in glass vials
Number of subjects: 1481
Study: 2114414

Group type: EXPERIMENTAL
Intervention: Lysine acetyl salicylate (Aspergesic) 1.8 g t.d.s.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg t.d.s.
Number of subjects: 24
Study: 352094

Group type: EXPERIMENTAL
Intervention: Clopenthixol decanoate
Number of subjects: 21
Study: 30806492

Group type: EXPERIMENTAL
Intervention: Acceptance-Based Treatment (ABT)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard Behavioral Treatment (SBT)
Number of subjects: 190
Study: 27283365

Group type: EXPERIMENTAL
Intervention: Enteral bovine colostrum, four times a day, till 21 days of life or discharge or death
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Enteral bovine colostrum
Number of subjects: 86
Study: 26088042

Group type: EXPERIMENTAL
Intervention: Hydration group (increased water intake by 1 to 1.5 l/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (usual fluid intake)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Hydration group (increased water intake)
Number of subjects: 29
Study: 24075206

Group type: EXPERIMENTAL
Intervention: Less Invasive Surfactant Administration (LISA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard treatment with intratracheal bolus administration of surfactant
Number of subjects: 1000
Study: 21682970

Group type: EXPERIMENTAL
Intervention: Delamanid 100 mg daily for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Delamanid 200 mg daily for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Delamanid 300 mg daily for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Delamanid 400 mg daily for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All dosages of Delamanid combined
Number of subjects: 48
Study: 19183825

Group type: EXPERIMENTAL
Intervention: Active intervention (drug therapy alone or combined with behavioral therapy) for 10 weeks
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Follow-up after stopping therapy for 6 months
Number of subjects: 307
Study: 16918122

Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 50
Study: 15572491

Group type: EXPERIMENTAL
Intervention: Buccal misoprostol (200-mcg tablet)
Number of subjects: 848

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 848
Study: 11489026

Group type: EXPERIMENTAL
Intervention: Handholding during surgery
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no handholding)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Handholding group
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 9859573

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibitors (Abciximab, tirofiban, lamifiban, integrelin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa inhibitors
Number of subjects: 0
Study: 8089244

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (0.12%) rinses, 15 ml, 2 times daily for 30 days starting 2 days after extraction
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo solution rinses for 30 days starting 2 days after extraction
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (0.12%) rinses
Number of subjects: 40
Study: 2700774

Group type: EXPERIMENTAL
Intervention: Tianeptine (37.5 mg/day)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Amitriptyline (75 mg/day)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Tianeptine and Amitriptyline
Number of subjects: 265
Study: 1105484

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 1000
Study: 31919695

Group type: EXPERIMENTAL
Intervention: Family-Based Treatment (FBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Parent-Based Treatment (PBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Hispanic families
Number of subjects: 150
Study: 31380506

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo inhaler
Number of subjects: 137
Study: 28205255

Group type: EXPERIMENTAL
Intervention: Maternal antiretroviral therapy (ART)
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: Infant nevirapine (NVP)
Number of subjects: 1472

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 1472
Study: 26153888

Group type: EXPERIMENTAL
Intervention: Neurocognitive Remediation Therapy (NCRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 22683294

Group type: EXPERIMENTAL
Intervention: Patient Activation Intervention (PAI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decision Aid video (DA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DA + PAI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 20129883

Group type: EXPERIMENTAL
Intervention: Sonic handpiece with precurved files
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nickel‐titanium rotary files
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sonic handpiece with straight files (control)
Number of subjects: 35
Study: 19097507

Group type: EXPERIMENTAL
Intervention: Acupuncture group (n = 33)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Medication group (n = 32)
Number of subjects: 65
Study: 15998785

Group type: EXPERIMENTAL
Intervention: Medium dairy, increase calcium intake to approximately 1000-1100 mg/d
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: High dairy, increase calcium intake to approximately 1200-1300 mg/d
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control, continuous established (<800 mg/d) dietary calcium intake
Number of subjects: 154
Study: 12122230

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Raloxifene 120 mg/day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 10747211

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Norepinephrine concentration increase
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Core temperature decrease
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Post-operative myocardial ischaemia
Number of subjects: 40
Study: 8537987

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 0
Study: 2073222

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 49
Study: 7141392

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) at 7 to 8 mg/kg/day and 14 to 15 mg/kg/day
Number of subjects: 223

Group type: COMPARATOR
Intervention: Chenodeoxycholic acid (CDCA) at 7 to 8 mg/kg/day and 14 to 15 mg/kg/day
Number of subjects: 223
Study: 31446153

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 29064743

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg QD + Metformin 1000 mg BID (COMBO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Metformin 1000 mg BID (MET)
Number of subjects: 24
Study: 25495769

Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound (PUS) therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Erythromycin phonophoresis (EP) therapy
Number of subjects: 60
Study: 23334901

Group type: EXPERIMENTAL
Intervention: ICD implantation with standard protocol for defibrillation testing
Number of subjects: 41
Study: 22778571

Group type: EXPERIMENTAL
Intervention: Introducer curving technique (Group T)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 108
Study: 19772445

Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin
Number of subjects: 500

Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 500
Study: 17136563

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate cream once daily for 4 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intramuscular alefacept 15 mg for 12 weeks
Number of subjects: 16
Study: 16863969

Group type: EXPERIMENTAL
Intervention: AcrySof Natural intraocular lens (IOL) in one eye
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional AcrySof IOL in the fellow eye
Number of subjects: 46
Study: 12590402

Group type: EXPERIMENTAL
Intervention: Mirtazapine (30 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Amitriptyline (75 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of mirtazapine and amitriptyline
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10755338

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressings (Comfeel and Varihesive)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional gauze dressing (control)
Number of subjects: 38
Study: 8665199

Group type: EXPERIMENTAL
Intervention: Haemorrhoidectomy plus lateral internal sphincterotomy (group 2)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Haemorrhoidectomy alone (control, group 1)
Number of subjects: 33
Study: 1503165

Group type: EXPERIMENTAL
Intervention: Smoking cessation program plus nicotine gum
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Smoking cessation program plus behavioral weight control
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Smoking cessation program plus both nicotine gum and behavioral weight control
Number of subjects: 417

Group type: COMPARATOR
Intervention: Standard smoking cessation program
Number of subjects: 417
Study: 6384455

Group type: EXPERIMENTAL
Intervention: Standard WHO oral glucose-electrolyte solution containing 90 mmol of sodium per liter (Group A: 22 infants)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Oral glucose-electrolyte solution containing 60 mmol of sodium per liter (Group B: 22 infants)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard intravenous therapy (Group C: 21 infants)
Number of subjects: 65
Study: 31868916

Group type: EXPERIMENTAL
Intervention: Fine-Needle Aspiration (FNA) for hepatic sampling
Number of subjects: 31

Group type: COMPARATOR
Intervention: Core Needle Biopsy (CNB)
Number of subjects: 31
Study: 28116988

Group type: EXPERIMENTAL
Intervention: Visuomotor feedback training (VFT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 20
Study: 29059263

Group type: EXPERIMENTAL
Intervention: Daily financial incentives of $60 monthly with $2 deducted for each day of nonadherence to glucose monitoring goals (4 or more checks per day, with 1 or more levels within the goal range of 70-180 mg/dL) during a 3-month intervention period.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no financial incentives).
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Daily financial incentives of $60 monthly with $2 deducted for each day of nonadherence to glucose monitoring goals during a 3-month intervention period.
Number of subjects: 90
Study: 25432449

Group type: EXPERIMENTAL
Intervention: Erbium:yttrium‐aluminum‐garnet laser
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional rotary instruments
Number of subjects: 15
Study: 23333553

Group type: EXPERIMENTAL
Intervention: Four isocaloric eating episodes at T0, T60, T120, and T180 min (F4)
Number of subjects: 20

Group type: COMPARATOR
Intervention: One eating episode at T0 (F1)
Number of subjects: 20
Study: 21275630

Group type: EXPERIMENTAL
Intervention: anti-B4-blocked ricin (anti-B4-bR)
Number of subjects: 157

Group type: COMPARATOR
Intervention: observation
Number of subjects: 157
Study: 19650746

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New inhibitors of the proton pump (potassium-competitive acid blockers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reflux inhibitors (GABA(B) receptor agonists and mGluR5 antagonists)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visceral analgesics and growth factors
Number of subjects: 0
Study: 16730271

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2500
Study: 14759379

Group type: EXPERIMENTAL
Intervention: Simvastatin plus niacin (mean daily dose 13 mg and 2.4 g, respectively)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Simvastatin plus niacin
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 11565960

Group type: EXPERIMENTAL
Intervention: Neurogenic stuttering
Number of subjects: 8

Group type: COMPARATOR
Intervention: Developmental stuttering
Number of subjects: 8
Study: 9414969

Group type: EXPERIMENTAL
Intervention: Lactose (34 g per day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sucrose (34 g per day)
Number of subjects: 46
Study: 8488995

Group type: EXPERIMENTAL
Intervention: Rüsch 'red rubber' tube (low‐volume, high‐pressure cuff)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Rüsch 'Super Safety Clear' tube (high‐volume, low‐pressure cuff)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mallinckrodt 'lo‐pro' tube (high‐volume, low‐pressure cuff)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 150
Study: 3716756

Group type: EXPERIMENTAL
Intervention: Bromocriptine (5 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 31705740

Group type: EXPERIMENTAL
Intervention: real continuous theta‐burst stimulation (cTBS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 16
Study: 29791971

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) treatment
Number of subjects: 135
Study: 28628502

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 26564457

Group type: EXPERIMENTAL
Intervention: Meibomian gland tube massage in addition to corticosteroid eye ointment and artificial tears
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroid eye ointment and artificial tears
Number of subjects: 0
Study: 23700337

Group type: EXPERIMENTAL
Intervention: Repeated Exposure (RE) group; 2 kJ/g; n = 32
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Flavor-Flavor Learning (FFL) group; 2 kJ/g; n = 32
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Flavor-Nutrient Learning (FNL) group; 6 kJ/g; n = 31
Number of subjects: 95
Study: 21684012

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 18285718

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES) before SEMS placement
Number of subjects: 74

Group type: COMPARATOR
Intervention: No Endoscopic sphincterotomy (ES) before SEMS placement
Number of subjects: 74
Study: 16777545

Group type: EXPERIMENTAL
Intervention: Influenza vaccination offered annually to all people after age 50
Number of subjects: 4000000

Group type: EXPERIMENTAL
Intervention: Influenza vaccination offered to persons aged 65 and older
Number of subjects: 4000000

Group type: EXPERIMENTAL
Intervention: Influenza vaccination for persons aged 65 and older
Number of subjects: 4000000

Group type: EXPERIMENTAL
Intervention: Influenza vaccination for persons aged 50 to 64
Number of subjects: 4000000

Group type: EXPERIMENTAL
Intervention: Influenza vaccination for persons aged 50 to 64 (excluding costs of patient time and travel)
Number of subjects: 4000000
Study: 14581723

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Both gentamicin and amikacin
Number of subjects: 25
Study: 14624189

Group type: EXPERIMENTAL
Intervention: Olanzapine (10-20 mg/d)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 583
Study: 10641042

Group type: EXPERIMENTAL
Intervention: Enteric-coated peppermint-caraway oil combination (90 mg peppermint oil and 50 mg caraway oil)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Non-enteric-coated peppermint-caraway oil combination (90 mg peppermint oil and 50 mg caraway oil)
Number of subjects: 6
Study: 8878595

Group type: EXPERIMENTAL
Intervention: Single dose of 2,000 mg of clarithromycin (CLARI) plus 200 mg of minocycline (MINO), with or without 800 mg of ofloxacin (OFLO)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single dose of 600 mg of rifampin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Month-long regimen with dapsone (DDS) and clofazimine (CLO) components of the standard MDT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Month-long standard regimen of multidrug therapy (MDT) for multibacillary leprosy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single dose of CLARI-MINO, with or without OFLO
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CLARI-MINO, with or without OFLO
Number of subjects: 50
Study: 1906152

Group type: EXPERIMENTAL
Intervention: hMGs following midluteal pre‐treatment with leuprolide
Number of subjects: 97

Group type: COMPARATOR
Intervention: hMGs alone
Number of subjects: 97
Study: 6506175

Group type: EXPERIMENTAL
Intervention: 39 mg elemental iron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 39 mg elemental iron plus 75 mg vitamin C
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100 mg vitamin C daily
Number of subjects: 0
Study: 31876673

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 29475874

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP) values 80-89 mm Hg
Number of subjects: 1703

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP) values 70-79 mm Hg
Number of subjects: 1703

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP) values 60-69 mm Hg
Number of subjects: 1703

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP) values < 60 mm Hg
Number of subjects: 1703
Study: 26708320

Group type: EXPERIMENTAL
Intervention: Agomelatine 10 mg/day
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day
Number of subjects: 426

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 426
Study: 24528999

Group type: EXPERIMENTAL
Intervention: p,p'-DDE
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: PCB 105 and 118
Number of subjects: 1016